Publication | Closed Access

Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?

ThrombosisHealth PolicyCardiovascular DiseasePatient SafetyOutcomes ResearchCardiologyAnticoagulantPharmacotherapyAcute Myocardial InfarctionPublic HealthMedicineGlycoprotein Iib/iiia AntagonistsAtherosclerosisEmergency MedicineCoronary Artery DiseaseMyocardial Infarction